South Korea in Vitro Diagnostics Market
Segments - by Test Types (Clinical Chemistry, Haematology, Immuno Diagnostics, Molecular Diagnostics, and Others), Products (Reagents, Instruments, and Others), Applications (Cardiology, Diabetes, Oncology, Infectious Diseases, Nephrology, Autoimmune Disease, and Others), End-users (Hospitals and Clinics, Diagnostics Laboratories, and Others), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The South Korea in vitro diagnostics market size is projected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the growing geriatric population and increasing demand for personalized medicines for variety of treatment.
In vitro diagnostic are tests that detects the diseases, infections and conditions. These tests can be conducted in hospitals, laboratories, and home with the help of various instruments ranging from small handheld tests to complex laboratory instruments.
In vitro diagnostic helps doctor to diagnose patients effectively and to provide the correct treatments. It requires assays and reagents to diagnose a medical condition.
In vitro diagnostic analyzes tissue samples and body fluids collected from a patient. It is also used in precision medicine to identify patients who gets benefit from specific therapies and treatments. In vitro diagnostic includes next generation sequencing tests, which scans the DNA of a person to detect genomic variations.
Market Trends, Drivers, Restraints, and Opportunities
- Growing incidences of infectious and chronic diseases is expected to boost the market growth during the forecast period.
- Rapid growth of the healthcare industry is key factor fueling the market expansion.
- Stringent rules and regulations by government act as major challenge that can hinder the market growth.
- High cost of in vitro diagnostics tests products is anticipated to restrict the market expansion in the coming years.
- R&D investment and technological advancement associated with in vitro diagnostics products & software is projected to offer significant opportunities for the market players.
Scope of In Vitro Diagnostics Market Report
The report on the South Korea in vitro diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
South Korea in Vitro Diagnostics Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Test Types (Clinical Chemistry, Haematology, Immuno Diagnostics, Molecular Diagnostics, and Others), Products (Reagents, Instruments, and Others), Applications (Cardiology, Diabetes, Oncology, Infectious Diseases, Nephrology, Autoimmune Disease, and Others), End-users (Hospitals and Clinics, Diagnostics Laboratories, and Others) |
|
Country |
South Korea |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Sysmex Corporation; Abbott Laboratories; Danaher Corporation; Becton, Dickinson and Company; Roche Diagnostics; Bio-Rad Laboratories Inc.; and Siemens Healthcare |
In Vitro Diagnostics Market Segment Insights:
Immuno diagnostics segment is projected to account for a large market share
Based on test types, the South Korea in vitro diagnostics market is divided into clinical chemistry, haematology, immuno diagnostics, molecular diagnostics, and others.
The immuno diagnostics segment is expected to constitute a key share of the market during the forecast period owing to high usage in detecting infectious microbes by detecting their toxins. Immuno diagnostics is highly accurate in detecting the diseases. However, the clinical chemistry segment is anticipated to expand at a rapid pace during the forecast period due to high usage in analyzing body fluids for therapeutic and diagnostics purposes.
Reagents segment is projected to hold a key market share
On the basis of products, the market is segmented into reagents, instruments, and others.
The reagents segment is expected to represent a key share of the market in the coming years due to reagents involved in every part of in vitro diagnostic test and rising demand for self-testing and point-of-care products. On the other hand, the instruments segment is anticipated to expand at a rapid pace during the forecast period owing to growing focus of market key players towards launching of new instruments.
Infectious diseases segment is projected to constitute a major market share
In terms of applications, the South Korea in vitro diagnostics market is segregated into cardiology, diabetes, oncology, infectious diseases, nephrology, autoimmune disease, and others.
The infectious diseases segment is expected to account for a key share of the market during the forecast period owing to rising incidences of pneumonia, hepatitis, tuberculosis, HIV-AIDS, and other infectious diseases.
Hospitals and clinics segment is projected to hold a key market share
On the basis of end-users, the market is segmented into hospitals and clinics, diagnostics laboratories, and others.
The hospitals and clinics segment is expected to represent a key share of the market in the coming years due to large amount of diagnostic testing required for supporting clinical decision enhancing patient recovery.
On the other hand, the diagnostics laboratories segment is anticipated to expand at a rapid pace during the forecast period owing to its collaborations with hospital for various operations.
Segments
The South Korea in vitro diagnostics market has been segmented on the basis of
Test Types
- Clinical Chemistry
- Haematology
- Immuno Diagnostics
- Molecular Diagnostics
- Others
Products
- Reagents
- Instruments
- Others
Applications
- Cardiology
- Diabetes
- Oncology
- Infectious Diseases
- Nephrology
- Autoimmune Disease
- Others
End-users
- Hospitals and Clinics
- Diagnostics Laboratories
- Others
Country
- South Korea
Key Players
- Sysmex Corporation
- Abbott Laboratories
- Danaher Corporation
- Becton, Dickinson and Company
- Roche Diagnostics
- Bio-Rad Laboratories Inc.
- Siemens Healthcare
Competitive Landscape
Key players competing in the South Korea in vitro diagnostics market include Sysmex Corporation; Abbott Laboratories; Danaher Corporation; Becton, Dickinson and Company; Roche Diagnostics; Bio-Rad Laboratories Inc.; and Siemens Healthcare.
Some of these players are engaged in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. For instance,
- In March 2020, Gencurix launched its new product, covid-19 rapid immunodiagnostics kit in Korea and European Union.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In Vitro Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. In Vitro Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. In Vitro Diagnostics Market - Supply Chain
4.5. Global In Vitro Diagnostics Market Forecast
4.5.1. In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. In Vitro Diagnostics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. In Vitro Diagnostics Market Absolute $ Opportunity
5. Global In Vitro Diagnostics Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. In Vitro Diagnostics Market Size and Volume Forecast by Types
5.3.1. Clinical Chemistry
5.3.2. Haematology
5.3.3. Immuno Diagnostics
5.3.4. Molecular Diagnostics
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global In Vitro Diagnostics Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. In Vitro Diagnostics Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global In Vitro Diagnostics Demand Share Forecast, 2019-2026
7. North America In Vitro Diagnostics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America In Vitro Diagnostics Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America In Vitro Diagnostics Market Size and Volume Forecast by Types
7.4.1. Clinical Chemistry
7.4.2. Haematology
7.4.3. Immuno Diagnostics
7.4.4. Molecular Diagnostics
7.4.5. Others
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America In Vitro Diagnostics Demand Share Forecast, 2019-2026
8. Latin America In Vitro Diagnostics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America In Vitro Diagnostics Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America In Vitro Diagnostics Market Size and Volume Forecast by Types
8.4.1. Clinical Chemistry
8.4.2. Haematology
8.4.3. Immuno Diagnostics
8.4.4. Molecular Diagnostics
8.4.5. Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America In Vitro Diagnostics Demand Share Forecast, 2019-2026
9. Europe In Vitro Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe In Vitro Diagnostics Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe In Vitro Diagnostics Market Size and Volume Forecast by Types
9.4.1. Clinical Chemistry
9.4.2. Haematology
9.4.3. Immuno Diagnostics
9.4.4. Molecular Diagnostics
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe In Vitro Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific In Vitro Diagnostics Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific In Vitro Diagnostics Market Size and Volume Forecast by Types
10.4.1. Clinical Chemistry
10.4.2. Haematology
10.4.3. Immuno Diagnostics
10.4.4. Molecular Diagnostics
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific In Vitro Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa In Vitro Diagnostics Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa In Vitro Diagnostics Market Size and Volume Forecast by Types
11.4.1. Clinical Chemistry
11.4.2. Haematology
11.4.3. Immuno Diagnostics
11.4.4. Molecular Diagnostics
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa In Vitro Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global In Vitro Diagnostics Market: Market Share Analysis
12.2. In Vitro Diagnostics Distributors and Customers
12.3. In Vitro Diagnostics Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Sysmex Corporation
12.4.2. Abbott Laboratories
12.4.3. Danaher Corporation
12.4.4. Becton, Dickinson and Company
12.4.5. Roche Diagnostics
12.4.6. Bio-Rad Laboratories Inc.
12.4.7. Siemens Healthcare
2. Assumptions and Acronyms Used
3. Research Methodology
4. In Vitro Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. In Vitro Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. In Vitro Diagnostics Market - Supply Chain
4.5. Global In Vitro Diagnostics Market Forecast
4.5.1. In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. In Vitro Diagnostics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. In Vitro Diagnostics Market Absolute $ Opportunity
5. Global In Vitro Diagnostics Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. In Vitro Diagnostics Market Size and Volume Forecast by Types
5.3.1. Clinical Chemistry
5.3.2. Haematology
5.3.3. Immuno Diagnostics
5.3.4. Molecular Diagnostics
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global In Vitro Diagnostics Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. In Vitro Diagnostics Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global In Vitro Diagnostics Demand Share Forecast, 2019-2026
7. North America In Vitro Diagnostics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America In Vitro Diagnostics Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America In Vitro Diagnostics Market Size and Volume Forecast by Types
7.4.1. Clinical Chemistry
7.4.2. Haematology
7.4.3. Immuno Diagnostics
7.4.4. Molecular Diagnostics
7.4.5. Others
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America In Vitro Diagnostics Demand Share Forecast, 2019-2026
8. Latin America In Vitro Diagnostics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America In Vitro Diagnostics Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America In Vitro Diagnostics Market Size and Volume Forecast by Types
8.4.1. Clinical Chemistry
8.4.2. Haematology
8.4.3. Immuno Diagnostics
8.4.4. Molecular Diagnostics
8.4.5. Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America In Vitro Diagnostics Demand Share Forecast, 2019-2026
9. Europe In Vitro Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe In Vitro Diagnostics Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe In Vitro Diagnostics Market Size and Volume Forecast by Types
9.4.1. Clinical Chemistry
9.4.2. Haematology
9.4.3. Immuno Diagnostics
9.4.4. Molecular Diagnostics
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe In Vitro Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific In Vitro Diagnostics Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific In Vitro Diagnostics Market Size and Volume Forecast by Types
10.4.1. Clinical Chemistry
10.4.2. Haematology
10.4.3. Immuno Diagnostics
10.4.4. Molecular Diagnostics
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific In Vitro Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa In Vitro Diagnostics Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa In Vitro Diagnostics Market Size and Volume Forecast by Types
11.4.1. Clinical Chemistry
11.4.2. Haematology
11.4.3. Immuno Diagnostics
11.4.4. Molecular Diagnostics
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa In Vitro Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global In Vitro Diagnostics Market: Market Share Analysis
12.2. In Vitro Diagnostics Distributors and Customers
12.3. In Vitro Diagnostics Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Sysmex Corporation
12.4.2. Abbott Laboratories
12.4.3. Danaher Corporation
12.4.4. Becton, Dickinson and Company
12.4.5. Roche Diagnostics
12.4.6. Bio-Rad Laboratories Inc.
12.4.7. Siemens Healthcare
Our Clients
Related Reports
Some other reports from this category!
